Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,661.00
71.5 (4.5%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 21.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,661.00",
    "chg": 71.5,
    "chgp": "4.5%",
    "dir": 1,
    "prev_price": "1,589.50",
    "mcapval": "92,957.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE406A01037",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "21:39 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "21.22 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1638.8",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs16388-4141872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AurobindoPharma_priceRelatedfactors_4141872.png",
        "date": "2026-08-07 11:35:07",
        "description": "Surging past its previous peaks, Aurobindo Pharma Ltd. touched a fresh 52-week high of Rs 1638.8 on 7 Aug 2026, marking a remarkable 52.7% gain over the past year. This milestone comes amid a backdrop of strong technical momentum that has propelled the stock well above its key moving averages, even as the broader Sensex trades lower."
      },
      {
        "title": "Aurobindo Pharma Ltd. Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-valuation-shifts-signal-changing-market-sentiment-4136631",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AurobindoPharma_valuationdot_4136631.png",
        "date": "2026-08-05 08:00:20",
        "description": "Aurobindo Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade from Buy to Hold. This change reflects a transition from fair to expensive valuation levels, raising questions about the stock's price attractiveness amid evolving market dynamics and peer comparisons."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4132266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AurobindoPharma_mojoScore_4132266.png",
        "date": "2026-08-02 10:10:28",
        "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4127759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_technicaldot_4127759.png",
        "date": "2026-07-30 08:00:17",
        "description": "Aurobindo Pharma Ltd. has demonstrated a notable shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend across multiple timeframes. This transition is underscored by positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, suggesting renewed investor interest and potential upside in the pharmaceutical sector amid broader market fluctuations."
      },
      {
        "title": "When is the next results date for Aurobindo Pharma Ltd.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aurobindo-pharma-ltd-4124743",
        "imagepath": "",
        "date": "2026-07-28 23:17:11",
        "description": "Aurobindo Pharma Ltd. will declare its results on 05 August 2026...."
      },
      {
        "title": "Aurobindo Pharma’s Mixed Week: -0.17% Price Change Amid Surging Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharmas-mixed-week--017-price-change-amid-surging-derivatives-activity-4121493",
        "imagepath": "",
        "date": "2026-07-26 16:03:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens strong at Rs.1,560.55 (+1.73%) amid stable market conditions</p>\n                    <p><strong>22 Jul:</strong> Sharp open interest surge in derivatives despite 3.01% price decline</p>\n                    <p><strong>24 Jul:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.1,531.50 (-0.17%) outperforming Sensex decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,534.05<..."
      },
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4118457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_technicaldot_4118457.png",
        "date": "2026-07-24 08:00:29",
        "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day decline of 0.59%, the stock’s technical indicators present a complex picture, with some signals suggesting sustained strength while others hint at caution. This nuanced technical landscape warrants close attention from investors seeking to navigate the stock’s evolving trend dynamics."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4116491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_oi_spurts_by_underlying_4116491.png",
        "date": "2026-07-22 15:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 13.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of volume patterns and price movements that investors must carefully analyse."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-price-action-4116418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_oi_spurts_by_underlying_4116418.png",
        "date": "2026-07-22 14:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 13.4% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders."
      }
    ],
    "total": 849,
    "sid": "164981",
    "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Aug-2026",
      "details": "Intimation of participation by the officials of the Company in the Investor/Analyst Meet to be held on August 11 to 13 2026 in Singapore & Hong Kong",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "05-Aug-2026",
      "details": "Submission of Press Release on financial results of the Company for the first quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
      "datetime": "05-Aug-2026",
      "details": "Intimation of proposal of merger of two wholly owned stepdown subsidiaries with a wholly owned subsidiary.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Aurobindo Pharma’s Mixed Week: -0.17% Price Change Amid Surging Derivatives Activity

2026-07-26 16:03:03

Key Events This Week

20 Jul: Stock opens strong at Rs.1,560.55 (+1.73%) amid stable market conditions

22 Jul: Sharp open interest surge in derivatives despite 3.01% price decline

24 Jul: Technical momentum shifts to mildly bullish with mixed indicator signals

24 Jul: Week closes at Rs.1,531.50 (-0.17%) outperforming Sensex decline

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-Aug-2026 | Source : BSE

Intimation of participation by the officials of the Company in the Investor/Analyst Meet to be held on August 11 to 13 2026 in Singapore & Hong Kong

Announcement under Regulation 30 (LODR)-Press Release / Media Release

05-Aug-2026 | Source : BSE

Submission of Press Release on financial results of the Company for the first quarter ended June 30 2026.

Announcement under Regulation 30 (LODR)-Restructuring

05-Aug-2026 | Source : BSE

Intimation of proposal of merger of two wholly owned stepdown subsidiaries with a wholly owned subsidiary.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aurobindo Pharma Ltd. has declared 400% dividend, ex-date: 08 Aug 25

stock-summary
SPLITS

Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11

stock-summary
BONUS

Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15

stock-summary
RIGHTS

No Rights history available